Medistim ASA
OSE:MEDI
Gross Margin
Medistim ASA
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | NO |
Market Cap | 3.3B NOK |
Gross Margin |
79%
|
Country | US |
Market Cap | 215.1B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 187.1B USD |
Gross Margin |
55%
|
Country | US |
Market Cap | 148.1B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 133.1B USD |
Gross Margin |
64%
|
Country | US |
Market Cap | 113.4B USD |
Gross Margin |
69%
|
Country | IE |
Market Cap | 110.2B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 69.9B USD |
Gross Margin |
41%
|
Country | DE |
Market Cap | 61.6B EUR |
Gross Margin |
38%
|
Country | US |
Market Cap | 53.1B USD |
Gross Margin |
77%
|
Country | CN |
Market Cap | 362.5B CNY |
Gross Margin |
65%
|
Profitability Report
View the profitability report to see the full profitability analysis for Medistim ASA.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Medistim ASA's most recent financial statements, the company has Gross Margin of 79%.